Showing results (11-20 of 1,794) with videos related to

Sort By:
Pageof 180
Mabs|June 21, 2019
Preclinical and translational pharmacokinetics of a novel THIOMAB™ antibody-antibiotic conjugate against Staphylococcus aureusRong Deng, Chenguang Zhou, Dongwei Li, et al.
Mabs|June 21, 2019
Looking for therapeutic antibodies in next-generation sequencing repositoriesKonrad Krawczyk, Matthew I J Raybould, Aleksandr Kovaltsuk, et al.
Mabs|July 26, 2016
Comparing domain interactions within antibody Fabs with kappa and lambda light chainsRaheleh Toughiri, Xiufeng Wu, Diana Ruiz, et al.
Mabs|May 12, 2015
A novel screening method to assess developability of antibody-like moleculesNeeraj Kohli, Nidhi Jain, Melissa L Geddie, et al.
Mabs|May 2, 2015
An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functionsMichelle Kinder, Allison R Greenplate, William R Strohl, et al.
Mabs|April 24, 2015
Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibodySanjaya Singh, Rachel R Kroe-Barrett, Keith A Canada, et al.
Mabs|April 21, 2015
A fluorescent imaging method for analyzing the biodistribution of therapeutic monoclonal antibodies that can distinguish intact antibodies from their breakdown productsTakuo Suzuki, Chihiro Miyazaki, Akiko Ishii-Watabe, et al.
Mabs|August 6, 2016
The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptorGanesh P Subedi, Adam W Barb
Mabs|April 5, 2021
TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHLHarbani K Malik-Chaudhry, Kirthana Prabhakar, Harshad S Ugamraj, et al.
Mabs|May 22, 2023
GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage deliveryLoes van Schie, Wander Van Breedam, Charlotte Roels, et al.
Pageof 180